NEWSLETTER
The Turning Point
Real-world perspectives on risk, resilience, and innovation in clinical supply chain.
A concise monthly briefing for leaders navigating uncertainty, anticipating disruption, and building more resilient clinical supply operations.
Designed for Clinical Supply Chain Leaders
Strategic Clarity
Make confident decisions with practical, evidence-based insights.
Market Intelligence
Gain timely insights into industry trends, disruptions, and evolving risks.
Operational Excellence
Learn practical approaches to strengthen planning, execution, and supply resilience.
AI & Digital Innovation
Understand how AI and data-driven technologies are reshaping the future of clinical supply.
LATEST ISSUE
Signal or Noise?
A note from our founder, marking three years of Boston Insights and the framework born from a defining moment in clinical supply.
This month marks three years since Boston Insights was founded. This issue revisits the moment that shaped that journey: a 2022 war room, where the challenge was not a lack of data, but the ability to identify which signal truly mattered. Every function reported an anomaly that week - most proved inconsequential, but one had the potential to alter the course of a trial.
The decision before the crisis.
A note from our founder on the war room meeting that changed how we think about clinical supply and why we started Boston Insights.
In early spring 2022, our founder was in a clinical supply war room with a top 10 pharma company, facing urgent questions triggered by the Russia-Ukraine conflict. No one had the answers-not because data didn't exist, but because it was fragmented across multiple systems.
This issue shares that moment, the real problem behind it, and why Boston Insights was founded to connect the signals that exist today-so leaders can act before disruption becomes crisis.
FROM THE FOUNDER
Neeraj Shah
Founder & CEO, Boston Insights
Clinical supply chain practitioner with over 20 years of experience helping pharmaceutical and biotechnology organizations improve visibility, reduce risk, and build resilient, data-driven supply operations.
The biggest clinical supply risks aren't caused by missing data - they're caused by disconnected decisions."